Grand Venture 'well-poised' to gain across segments: DBS
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.
The research team on Thursday (Apr 14) initiated coverage on the precision manufacturing company with a "buy" call and target price of S$1.50, as it assumes revenue will grow by 25 per cent in FY2022 and 22.5 per cent in FY2023.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
